Industry Fears 'Double Taxation' For Combo Products, Device Kits
This article was originally published in The Pink Sheet Daily
Executive Summary
IRS is developing guidance to implement a 2.3% device tax created by the health care reform law and set to go into effect on Jan. 1, 2013. But companies selling drug-device combination products are concerned that they could be liable for both the device tax and a prescription drug manufacturer fee also established in the 2010 reforms.